Cointime

Aileron Therapeutics

company

About

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

  • 1 - 10

Highlights

Total Funding Amount
$35.90M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Secondary
Last Funding Money Raised
$35.90M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$35.90M
Aileron Therapeutics has raised a total of $35.90M in funding over 2 rounds. Their latest funding was raised on Jan 6, 2021 from a Post-IPO Secondary round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 6, 2021 Post-IPO Secondary $35.90M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Aileron Therapeutics is funded by 1 investors. Maven Investment Partners US are the most recent investors.
Investor Name Lead Investor Funding Round
Maven Investment Partners US — Post-IPO Secondary
Cointime
เนื้อหา
บริษัท